326 related articles for article (PubMed ID: 22998728)
1. Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway.
Inoue K; Rispoli J; Kaphzan H; Klann E; Chen EI; Kim J; Komatsu M; Abeliovich A
Mol Neurodegener; 2012 Sep; 7():48. PubMed ID: 22998728
[TBL] [Abstract][Full Text] [Related]
2. Coordinate regulation of mature dopaminergic axon morphology by macroautophagy and the PTEN signaling pathway.
Inoue K; Rispoli J; Yang L; Macleod D; Beal MF; Klann E; Abeliovich A
PLoS Genet; 2013; 9(10):e1003845. PubMed ID: 24098148
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
4. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration.
Ramesh Babu J; Lamar Seibenhener M; Peng J; Strom AL; Kemppainen R; Cox N; Zhu H; Wooten MC; Diaz-Meco MT; Moscat J; Wooten MW
J Neurochem; 2008 Jul; 106(1):107-20. PubMed ID: 18346206
[TBL] [Abstract][Full Text] [Related]
5. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β.
Maurin H; Lechat B; Borghgraef P; Devijver H; Jaworski T; Van Leuven F
Eur J Neurosci; 2014 Jul; 40(2):2442-53. PubMed ID: 24754737
[TBL] [Abstract][Full Text] [Related]
6. Assembly of filamentous tau aggregates in human neuronal cells.
Ko LW; Rush T; Sahara N; Kersh JS; Easson C; Deture M; Lin WL; Connor YD; Yen SH
J Alzheimers Dis; 2004 Dec; 6(6):605-22; discussion 673-81. PubMed ID: 15665401
[TBL] [Abstract][Full Text] [Related]
7. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
8. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
[TBL] [Abstract][Full Text] [Related]
9. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
Giacomini C; Koo CY; Yankova N; Tavares IA; Wray S; Noble W; Hanger DP; Morris JDH
Acta Neuropathol Commun; 2018 May; 6(1):37. PubMed ID: 29730992
[TBL] [Abstract][Full Text] [Related]
10. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
11. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
12. Neurodegeneration Caused by S1P-Lyase Deficiency Involves Calcium-Dependent Tau Pathology and Abnormal Histone Acetylation.
Alam S; Piazzesi A; Abd El Fatah M; Raucamp M; van Echten-Deckert G
Cells; 2020 Sep; 9(10):. PubMed ID: 32998447
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration.
Nakamori M; Takahashi T; Yamazaki Y; Kurashige T; Yamawaki T; Matsumoto M
Neuroreport; 2012 Oct; 23(15):867-72. PubMed ID: 22968343
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
15. Interplay of pathogenic forms of human tau with different autophagic pathways.
Caballero B; Wang Y; Diaz A; Tasset I; Juste YR; Stiller B; Mandelkow EM; Mandelkow E; Cuervo AM
Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29024336
[TBL] [Abstract][Full Text] [Related]
16. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
Vingtdeux V; Davies P; Dickson DW; Marambaud P
Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
[TBL] [Abstract][Full Text] [Related]
17. Lysosome dysfunction triggers Atg7-dependent neural apoptosis.
Walls KC; Ghosh AP; Franklin AV; Klocke BJ; Ballestas M; Shacka JJ; Zhang J; Roth KA
J Biol Chem; 2010 Apr; 285(14):10497-507. PubMed ID: 20123985
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Atg5/Atg7-independent alternative macroautophagy.
Nishida Y; Arakawa S; Fujitani K; Yamaguchi H; Mizuta T; Kanaseki T; Komatsu M; Otsu K; Tsujimoto Y; Shimizu S
Nature; 2009 Oct; 461(7264):654-8. PubMed ID: 19794493
[TBL] [Abstract][Full Text] [Related]
19. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.
Shen LL; Li WW; Xu YL; Gao SH; Xu MY; Bu XL; Liu YH; Wang J; Zhu J; Zeng F; Yao XQ; Gao CY; Xu ZQ; Zhou XF; Wang YJ
Neurobiol Dis; 2019 Dec; 132():104567. PubMed ID: 31394202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
